HEADER TRANSFERASE/TRANSFERASE INHIBITOR 07-MAY-22 7UYR TITLE CRYSTAL STRUCTURE OF TYK2 KINASE DOMAIN IN COMPLEX WITH COMPOUND 12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2; COMPND 3 CHAIN: A; COMPND 4 EC: 2.7.10.2; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS NON-RECEPTOR TYROSINE-PROTEIN KINASE 2, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.V.TOMS,S.LEIT,J.R.GREENWOOD,S.MONDAL,S.CARRIERO,M.DAHLGREN, AUTHOR 2 G.C.HARRIMAN,J.J.KENNEDY-SMITH,R.KAPELLER,J.P.LAWSON,D.L.ROMERO, AUTHOR 3 M.SHELLEY,R.T.WESTER,W.WESTLIN,J.J.MC ELWEE,W.MIAO,S.D.EDMONDSON, AUTHOR 4 C.E.MASSEE REVDAT 2 16-OCT-24 7UYR 1 REMARK REVDAT 1 24-AUG-22 7UYR 0 JRNL AUTH S.LEIT,J.R.GREENWOOD,S.MONDAL,S.CARRIERO,M.DAHLGREN, JRNL AUTH 2 G.C.HARRIMAN,J.J.KENNEDY-SMITH,R.KAPELLER,J.P.LAWSON, JRNL AUTH 3 D.L.ROMERO,A.V.TOMS,M.SHELLEY,R.T.WESTER,W.WESTLIN, JRNL AUTH 4 J.J.MCELWEE,W.MIAO,S.D.EDMONDSON,C.E.MASSE JRNL TITL POTENT AND SELECTIVE TYK2-JH1 INHIBITORS HIGHLY EFFICACIOUS JRNL TITL 2 IN RODENT MODEL OF PSORIASIS. JRNL REF BIOORG.MED.CHEM.LETT. V. 73 28891 2022 JRNL REFN ESSN 1464-3405 JRNL PMID 35842205 JRNL DOI 10.1016/J.BMCL.2022.128891 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 14174 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1426 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1045 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.31 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 117 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2297 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 83 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.44000 REMARK 3 B22 (A**2) : -1.37000 REMARK 3 B33 (A**2) : 3.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.325 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.240 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.186 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.501 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2373 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2188 ; 0.003 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3233 ; 1.566 ; 1.672 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5020 ; 1.345 ; 1.595 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 289 ; 6.965 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 110 ;34.881 ;21.909 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 366 ;14.672 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;17.743 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 292 ; 0.071 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2693 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 553 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 890 A 979 REMARK 3 ORIGIN FOR THE GROUP (A): 7.480 12.248 -6.293 REMARK 3 T TENSOR REMARK 3 T11: 0.3192 T22: 0.2049 REMARK 3 T33: 0.2049 T12: -0.0136 REMARK 3 T13: -0.0195 T23: -0.0142 REMARK 3 L TENSOR REMARK 3 L11: 2.5334 L22: 4.5757 REMARK 3 L33: 1.9877 L12: -1.1486 REMARK 3 L13: 0.2436 L23: 0.4049 REMARK 3 S TENSOR REMARK 3 S11: 0.0035 S12: -0.3289 S13: 0.1041 REMARK 3 S21: 0.4251 S22: 0.0191 S23: 0.2345 REMARK 3 S31: -0.1260 S32: -0.2485 S33: -0.0226 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 983 A 1177 REMARK 3 ORIGIN FOR THE GROUP (A): 13.028 -8.258 -21.488 REMARK 3 T TENSOR REMARK 3 T11: 0.0618 T22: 0.0014 REMARK 3 T33: 0.0930 T12: 0.0036 REMARK 3 T13: 0.0051 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 2.2882 L22: 3.2313 REMARK 3 L33: 1.0982 L12: -0.1995 REMARK 3 L13: 0.0473 L23: -0.1657 REMARK 3 S TENSOR REMARK 3 S11: 0.0303 S12: 0.0000 S13: -0.0343 REMARK 3 S21: 0.0375 S22: -0.0532 S23: -0.1261 REMARK 3 S31: 0.0099 S32: -0.0126 S33: 0.0229 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 7UYR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265205. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15600 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 34.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.44400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS OF HUMAN TYK2 IN COMPLEX WITH REMARK 280 THE LIGAND WERE PREPARED ACCORDING TO ESTABLISHED PROTOCOLS, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.09350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.45000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.45000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.09350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 889 REMARK 465 GLU A 1050 REMARK 465 GLY A 1051 REMARK 465 HIS A 1052 REMARK 465 GLU A 1059 REMARK 465 ASP A 1060 REMARK 465 GLY A 1061 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 936 SG REMARK 470 GLN A 969 CG CD OE1 NE2 REMARK 470 GLU A 971 CG CD OE1 OE2 REMARK 470 LYS A 972 CG CD CE NZ REMARK 470 CYS A1142 SG REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 THR A 890 OG1 CG2 REMARK 480 LYS A 894 CG CD CE NZ REMARK 480 LYS A 898 CD CE NZ REMARK 480 PHE A 908 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS A 910 CG CD CE NZ REMARK 480 THR A 923 OG1 CG2 REMARK 480 GLU A 925 CG CD OE1 OE2 REMARK 480 LYS A 933 CG CD CE NZ REMARK 480 ASP A 935 CG OD1 OD2 REMARK 480 GLN A 939 CG CD OE1 NE2 REMARK 480 LYS A 945 NZ REMARK 480 ASP A 949 CG OD1 OD2 REMARK 480 LEU A 951 CD1 CD2 REMARK 480 ARG A 952 CZ NH1 NH2 REMARK 480 GLU A 967 CG CD OE1 OE2 REMARK 480 ARG A 987 NE CZ NH1 NH2 REMARK 480 ASP A 988 CG OD1 OD2 REMARK 480 GLU A 1053 CD OE1 OE2 REMARK 480 ARG A 1058 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 1074 NZ REMARK 480 LYS A 1077 CE NZ REMARK 480 ARG A 1123 CZ NH1 NH2 REMARK 480 LYS A 1139 CD CE NZ REMARK 480 LYS A 1175 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 947 O HOH A 1302 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 THR A 890 CB THR A 890 CG2 -0.366 REMARK 500 THR A 923 CB THR A 923 OG1 0.128 REMARK 500 GLU A 925 CB GLU A 925 CG -0.363 REMARK 500 LYS A 933 CB LYS A 933 CG -0.437 REMARK 500 ASP A 935 CB ASP A 935 CG 0.193 REMARK 500 LYS A 945 CE LYS A 945 NZ -0.183 REMARK 500 GLU A 967 CB GLU A 967 CG 0.260 REMARK 500 MET A 978 C MET A 978 O 0.119 REMARK 500 ARG A 987 CD ARG A 987 NE -0.208 REMARK 500 GLU A1053 CG GLU A1053 CD -0.101 REMARK 500 ARG A1058 CB ARG A1058 CG -0.326 REMARK 500 LYS A1074 CE LYS A1074 NZ -0.171 REMARK 500 ARG A1123 NE ARG A1123 CZ 0.151 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 890 OG1 - CB - CG2 ANGL. DEV. = 23.2 DEGREES REMARK 500 THR A 923 CA - CB - OG1 ANGL. DEV. = -12.8 DEGREES REMARK 500 GLU A 925 CA - CB - CG ANGL. DEV. = 14.0 DEGREES REMARK 500 LYS A 933 CA - CB - CG ANGL. DEV. = 20.4 DEGREES REMARK 500 ASP A 935 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 949 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 952 CD - NE - CZ ANGL. DEV. = 8.8 DEGREES REMARK 500 ARG A 952 NE - CZ - NH1 ANGL. DEV. = -6.8 DEGREES REMARK 500 ARG A 952 NE - CZ - NH2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 920 15.72 83.39 REMARK 500 LYS A 972 58.78 39.49 REMARK 500 SER A 973 -167.46 -164.23 REMARK 500 SER A 994 93.69 -61.00 REMARK 500 ASP A1023 43.74 -155.34 REMARK 500 ASP A1034 -15.07 -47.09 REMARK 500 CYS A1098 41.89 39.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 952 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 7UYR A 889 1177 UNP P29597 TYK2_HUMAN 889 1177 SEQRES 1 A 289 PRO THR VAL PHE HIS LYS ARG TYR LEU LYS LYS ILE ARG SEQRES 2 A 289 ASP LEU GLY GLU GLY HIS PHE GLY LYS VAL SER LEU TYR SEQRES 3 A 289 CYS TYR ASP PRO THR ASN ASP GLY THR GLY GLU MET VAL SEQRES 4 A 289 ALA VAL LYS ALA LEU LYS ALA ASP CYS GLY PRO GLN HIS SEQRES 5 A 289 ARG SER GLY TRP LYS GLN GLU ILE ASP ILE LEU ARG THR SEQRES 6 A 289 LEU TYR HIS GLU HIS ILE ILE LYS TYR LYS GLY CYS CYS SEQRES 7 A 289 GLU ASP GLN GLY GLU LYS SER LEU GLN LEU VAL MET GLU SEQRES 8 A 289 TYR VAL PRO LEU GLY SER LEU ARG ASP TYR LEU PRO ARG SEQRES 9 A 289 HIS SER ILE GLY LEU ALA GLN LEU LEU LEU PHE ALA GLN SEQRES 10 A 289 GLN ILE CYS GLU GLY MET ALA TYR LEU HIS ALA GLN HIS SEQRES 11 A 289 TYR ILE HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU LEU SEQRES 12 A 289 ASP ASN ASP ARG LEU VAL LYS ILE GLY ASP PHE GLY LEU SEQRES 13 A 289 ALA LYS ALA VAL PRO GLU GLY HIS GLU PTR PTR ARG VAL SEQRES 14 A 289 ARG GLU ASP GLY ASP SER PRO VAL PHE TRP TYR ALA PRO SEQRES 15 A 289 GLU CYS LEU LYS GLU TYR LYS PHE TYR TYR ALA SER ASP SEQRES 16 A 289 VAL TRP SER PHE GLY VAL THR LEU TYR GLU LEU LEU THR SEQRES 17 A 289 HIS CYS ASP SER SER GLN SER PRO PRO THR LYS PHE LEU SEQRES 18 A 289 GLU LEU ILE GLY ILE ALA GLN GLY GLN MET THR VAL LEU SEQRES 19 A 289 ARG LEU THR GLU LEU LEU GLU ARG GLY GLU ARG LEU PRO SEQRES 20 A 289 ARG PRO ASP LYS CYS PRO CYS GLU VAL TYR HIS LEU MET SEQRES 21 A 289 LYS ASN CYS TRP GLU THR GLU ALA SER PHE ARG PRO THR SEQRES 22 A 289 PHE GLU ASN LEU ILE PRO ILE LEU LYS THR VAL HIS GLU SEQRES 23 A 289 LYS TYR GLN MODRES 7UYR PTR A 1054 TYR MODIFIED RESIDUE MODRES 7UYR PTR A 1055 TYR MODIFIED RESIDUE HET PTR A1054 16 HET PTR A1055 16 HET OVI A1201 44 HETNAM PTR O-PHOSPHOTYROSINE HETNAM OVI 2-(4-{[2-(2,6-DIFLUOROPHENYL)-5-OXO-5H-PYRROLO[3,4- HETNAM 2 OVI D]PYRIMIDIN-4-YL]AMINO}PHENYL)-N-ETHYLACETAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 OVI C22 H17 F2 N5 O2 FORMUL 3 HOH *83(H2 O) HELIX 1 AA1 HIS A 893 ARG A 895 5 3 HELIX 2 AA2 GLY A 937 LEU A 954 1 18 HELIX 3 AA3 SER A 985 LEU A 990 1 6 HELIX 4 AA4 GLY A 996 GLN A 1017 1 22 HELIX 5 AA5 ALA A 1025 ARG A 1027 5 3 HELIX 6 AA6 PRO A 1064 TYR A 1068 5 5 HELIX 7 AA7 ALA A 1069 TYR A 1076 1 8 HELIX 8 AA8 TYR A 1080 THR A 1096 1 17 HELIX 9 AA9 ASP A 1099 GLN A 1102 5 4 HELIX 10 AB1 SER A 1103 GLY A 1113 1 11 HELIX 11 AB2 GLN A 1116 GLN A 1118 5 3 HELIX 12 AB3 MET A 1119 ARG A 1130 1 12 HELIX 13 AB4 PRO A 1141 TRP A 1152 1 12 HELIX 14 AB5 GLU A 1155 ARG A 1159 5 5 HELIX 15 AB6 THR A 1161 GLN A 1177 1 17 SHEET 1 AA1 6 VAL A 891 PHE A 892 0 SHEET 2 AA1 6 TYR A 962 ASP A 968 1 O CYS A 965 N PHE A 892 SHEET 3 AA1 6 SER A 973 GLU A 979 -1 O VAL A 977 N LYS A 963 SHEET 4 AA1 6 GLU A 925 LYS A 930 -1 N ALA A 928 O MET A 978 SHEET 5 AA1 6 LYS A 910 TYR A 916 -1 N TYR A 914 O VAL A 927 SHEET 6 AA1 6 LEU A 897 GLU A 905 -1 N ARG A 901 O LEU A 913 SHEET 1 AA2 2 TYR A1019 ILE A1020 0 SHEET 2 AA2 2 LYS A1046 ALA A1047 -1 O LYS A1046 N ILE A1020 SHEET 1 AA3 2 VAL A1029 ASN A1033 0 SHEET 2 AA3 2 LEU A1036 ILE A1039 -1 O LEU A1036 N ASN A1033 SHEET 1 AA4 2 PTR A1054 ARG A1056 0 SHEET 2 AA4 2 LYS A1077 TYR A1079 -1 O PHE A1078 N PTR A1055 LINK C GLU A1053 N PTR A1054 1555 1555 1.34 LINK C PTR A1054 N PTR A1055 1555 1555 1.33 LINK C PTR A1055 N ARG A1056 1555 1555 1.33 CRYST1 36.187 74.240 106.900 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027634 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013470 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009355 0.00000